These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8841080)

  • 1. Contemporary chemotherapy issues for children with brainstem gliomas.
    Allen JC; Siffert J
    Pediatr Neurosurg; 1996; 24(2):98-102. PubMed ID: 8841080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group.
    Cohen BH; Geyer JR; Miller DC; Curran JG; Zhou T; Holmes E; Ingles SA; Dunkel IJ; Hilden J; Packer RJ; Pollack IF; Gajjar A; Finlay JL;
    Pediatr Neurol; 2015 Jul; 53(1):31-46. PubMed ID: 26092413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.
    Packer RJ; Ater J; Allen J; Phillips P; Geyer R; Nicholson HS; Jakacki R; Kurczynski E; Needle M; Finlay J; Reaman G; Boyett JM
    J Neurosurg; 1997 May; 86(5):747-54. PubMed ID: 9126887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
    Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
    Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group.
    Dunkel IJ; Garvin JH; Goldman S; Ettinger LJ; Kaplan AM; Cairo M; Li H; Boyett JM; Finlay JL
    J Neurooncol; 1998 Mar; 37(1):67-73. PubMed ID: 9525840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support.
    van der Lelie H; Baars JW; Rodenhuis S; van Dijk MA; de Glas-Vos CW; Thomas BL; van Oers RH; von dem Borne AE
    Cancer; 1995 Dec; 76(11):2338-42. PubMed ID: 8635040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group.
    Jennings MT; Sposto R; Boyett JM; Vezina LG; Holmes E; Berger MS; Bruggers CS; Bruner JM; Chan KW; Dusenbery KE; Ettinger LJ; Fitz CR; Lafond D; Mandelbaum DE; Massey V; McGuire W; McNeely L; Moulton T; Pollack IF; Shen V
    J Clin Oncol; 2002 Aug; 20(16):3431-7. PubMed ID: 12177103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
    Newton HB; Slivka MA; Stevens CL; Bourekas EC; Christoforidis GA; Baujan MA; Chakeres DW
    J Neurooncol; 2002 Jan; 56(1):79-86. PubMed ID: 11949830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
    Linassier C; Destrieux C; Benboubker L; Alcaraz L; Bergemer-Fouquet AM; Jan M; Calais G; Colombat P
    Bull Cancer; 2001 Sep; 88(9):871-6. PubMed ID: 11604360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study.
    Walter AW; Gajjar A; Ochs JS; Langston JW; Sanford RA; Kun LE; Heideman R
    Med Pediatr Oncol; 1998 Jan; 30(1):28-33. PubMed ID: 9371386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.
    Osztie E; Várallyay P; Doolittle ND; Lacy C; Jones G; Nickolson HS; Neuwelt EA
    AJNR Am J Neuroradiol; 2001 May; 22(5):818-23. PubMed ID: 11337321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors.
    Guruangan S; Dunkel IJ; Goldman S; Garvin JH; Rosenblum M; Boyett JM; Gardner S; Merchant TE; Gollamudi S; Finlay JL
    J Clin Oncol; 1998 Jul; 16(7):2486-93. PubMed ID: 9667268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
    Finlay JL; Goldman S; Wong MC; Cairo M; Garvin J; August C; Cohen BH; Stanley P; Zimmerman RA; Bostrom B; Geyer JR; Harris RE; Sanders J; Yates AJ; Boyett JM; Packer RJ
    J Clin Oncol; 1996 Sep; 14(9):2495-503. PubMed ID: 8823328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme.
    Aoki T; Mizutani T; Nojima K; Takagi T; Okumura R; Yuba Y; Ueba T; Takahashi JA; Miyatake S; Nozaki K; Taki W; Matsutani M
    J Neurosurg; 2010 Jan; 112(1):50-6. PubMed ID: 19538050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.